| 55.90 Data as of May 17 |  -0.04 / -0.07%Today’s Change | 39.93 Today|||52-Week Range 58.41 | +13.34% Year-to-Date |
| AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward May 16 / TheStreet.com | Eli Lilly And Stock To Go Ex-dividend Tomorrow (LLY) May 13 / TheStreet.com |
| Eli Lilly And Company (LLY): Today's Featured Drugs Winner May 15 / TheStreet.com | Time to Cash In Actavis May 13 / TheStreet.com |
| Amgen to Set Up JV in China - Analyst Blog May 14 / Zacks.com | Novo Nordisk / Lundbeck: drugs start working May 01 / FT.com |
| Big Cap Pharma Is Turning Up May 14 / StockTwits | Investors: Look beyond Merck's patent loss May 01 / Money |
| Lilly Scraps Oncology Candidate - Analyst Blog May 13 / Zacks.com | US pharma: spot the difference Apr 29 / FT.com |
| Previous close | 55.94 |
| Today’s open | 55.97 |
| Day’s range | 55.35 - 56.23 |
| Volume | 3,763,076 |
| Average volume (3 months) | 5,115,476 |
| Market cap | $63.0B |
| Dividend yield | 3.51% |
| Earnings growth (last year) | -6.15% |
| Earnings growth (this year) | +15.51% |
| Earnings growth (next 5 years) | -1.20% |
| Revenue growth (last year) | -6.93% |
| P/E ratio | 13.4 |
| Price/Sales | 2.43 |
| Price/Book | 4.33 |
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca PLC | -0.27 | -0.52% |
| ABTAbbott Laboratories | -0.24 | -0.65% |
| BMYBristol-Myers Squibb... | +0.53 | +1.24% |
| CELGCelgene Corp | +1.43 | +1.16% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $1.00 |
| Annual revenue (last year) | $22.6B |
| Annual profit (last year) | $4.1B |
| Net profit margin | 18.09% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer John C. Lechleiter, PhD |
Chief Financial Officer & EVP-Global Services Derica W. Rice, MBA |
Corporate headquarters Indianapolis, Indiana |
.
